"Analgesics in Argentina" Now Available at Fast Market Research
Analgesics performed well in 2012, with current value growth of 14%. This was due in large part to the sales results of ibuprofen, especially Actron (Bayer Argentina SA). Players strengthened the communication of ibuprofen using important leaders of public opinion in their advertising: IBU 400 (Instituto Seroterapico Argentino SAIC), Ibuprofeno Elisium (Elisium SA) and Ibupirac (Pfizer SRL).
View full press release